JP2015509500A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509500A5 JP2015509500A5 JP2014558832A JP2014558832A JP2015509500A5 JP 2015509500 A5 JP2015509500 A5 JP 2015509500A5 JP 2014558832 A JP2014558832 A JP 2014558832A JP 2014558832 A JP2014558832 A JP 2014558832A JP 2015509500 A5 JP2015509500 A5 JP 2015509500A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- eye
- macular
- administered
- rectus muscle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261601878P | 2012-02-22 | 2012-02-22 | |
| US61/601,878 | 2012-02-22 | ||
| US201261605576P | 2012-03-01 | 2012-03-01 | |
| US61/605,576 | 2012-03-01 | ||
| PCT/US2013/027175 WO2013126597A1 (en) | 2012-02-22 | 2013-02-21 | Methods and compositions for preventing or treating ophthalmic conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017111746A Division JP2017214380A (ja) | 2012-02-22 | 2017-06-06 | 眼疾患を予防または治療するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015509500A JP2015509500A (ja) | 2015-03-30 |
| JP2015509500A5 true JP2015509500A5 (https=) | 2016-04-07 |
Family
ID=49006208
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014558832A Pending JP2015509500A (ja) | 2012-02-22 | 2013-02-21 | 眼疾患を予防または治療するための方法および組成物 |
| JP2017111746A Pending JP2017214380A (ja) | 2012-02-22 | 2017-06-06 | 眼疾患を予防または治療するための方法および組成物 |
| JP2018189741A Pending JP2019034947A (ja) | 2012-02-22 | 2018-10-05 | 眼疾患を予防または治療するための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017111746A Pending JP2017214380A (ja) | 2012-02-22 | 2017-06-06 | 眼疾患を予防または治療するための方法および組成物 |
| JP2018189741A Pending JP2019034947A (ja) | 2012-02-22 | 2018-10-05 | 眼疾患を予防または治療するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20150018288A1 (https=) |
| EP (4) | EP3281634A1 (https=) |
| JP (3) | JP2015509500A (https=) |
| CN (2) | CN104244964A (https=) |
| AU (3) | AU2013222423A1 (https=) |
| CA (1) | CA2865317A1 (https=) |
| HK (1) | HK1204988A1 (https=) |
| WO (1) | WO2013126597A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9687519B2 (en) | 2013-03-01 | 2017-06-27 | Stealth Biotherapeutics Corp | Methods and compositions for the prevention or treatment of barth syndrome |
| ES2755134T3 (es) * | 2013-03-01 | 2020-04-21 | Stealth Biotherapeutics Corp | Métodos para el tratamiento de enfermedad mitocondrial |
| CA2916977A1 (en) | 2013-06-26 | 2014-12-31 | Stealth Biotherapeutics Corp | Methods and compositions for detecting and diagnosing diseases and conditions |
| CA2919992C (en) * | 2013-08-01 | 2022-08-09 | Stealth Biotherapeutics Corp | Methods and compositions for preventing or treating leber's hereditary optic neuropathy |
| US10221213B2 (en) | 2013-12-27 | 2019-03-05 | Stealth Biotherapeutics Corp | Pharmaceutically relevant aromatic-cationic peptides |
| WO2015103577A1 (en) * | 2014-01-06 | 2015-07-09 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating dominant optic atrophy |
| CA2941518A1 (en) * | 2014-03-03 | 2015-09-11 | Encore Vision, Inc. | Lipoic acid choline ester compositions and methods of use |
| JP2017512762A (ja) * | 2014-03-03 | 2017-05-25 | ステルス バイオセラピューティックス コープ | 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法 |
| EP3265109B1 (en) | 2015-03-06 | 2020-10-21 | Stealth BioTherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
| CA3017359A1 (en) | 2016-03-11 | 2017-09-14 | Scott M. Duncan | Crystalline salt forms |
| WO2017180535A1 (en) | 2016-04-11 | 2017-10-19 | Carnot, Llc | Chiral peptides |
| US11034724B2 (en) | 2017-04-05 | 2021-06-15 | Stealth Biotherapeutics Corp. | Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2 |
| US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
| KR20210138596A (ko) * | 2019-02-08 | 2021-11-19 | 오하이오 스테이트 이노베이션 파운데이션 | 치료제의 안구 투여용 약물전달 조성물 및 이의 사용방법 |
| EP3771467A1 (en) * | 2019-07-30 | 2021-02-03 | Fundacio Institut de Recerca de l'Hospital de la Santa Creu i sant Pau | Ss-31 for the prevention and/or treatment of aneurysm |
| WO2021216909A1 (en) * | 2020-04-23 | 2021-10-28 | Okogen, Inc. | Treatment of viral conjunctivitis |
| KR102429281B1 (ko) * | 2020-05-25 | 2022-08-05 | (주)노바셀테크놀로지 | 신규 안구건조증 치료용 약학적 조성물 |
| WO2023279067A1 (en) * | 2021-07-01 | 2023-01-05 | The Regents Of The University Of California | Targeting piezo1 to treat inherited and age-related macular degenerations |
| CN113975402B (zh) * | 2021-07-19 | 2023-05-16 | 河南大学 | 靶向脑缺血区线粒体的神经保护药物ss31-ha-qt及其荧光探针和应用 |
| WO2023069549A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| CN115252555B (zh) * | 2022-06-07 | 2023-11-21 | 西安电子科技大学 | 一种膜融合性脂质体、制备方法及其在蛋白质递送中的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US781405A (en) | 1903-09-03 | 1905-01-31 | Marcus A Coykendall | Blank for dental plates. |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| CA2321560C (en) * | 1998-03-13 | 2007-05-22 | Johns Hopkins University School Of Medicine | The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| US6217896B1 (en) | 1999-04-01 | 2001-04-17 | Uab Research Foundation | Conjunctival inserts for topical delivery of medication or lubrication |
| CA3024434A1 (en) * | 2004-01-23 | 2005-08-11 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| CN104788540B (zh) * | 2005-09-16 | 2019-10-18 | 科内尔研究基金会 | 用于减少cd36表达的方法 |
| ES2830024T3 (es) * | 2007-10-19 | 2021-06-02 | Novartis Ag | Composiciones y métodos para el tratamiento del edema macular |
| EP2712620A1 (en) * | 2008-02-07 | 2014-04-02 | Cornell University | Methods for Preventing or Treating Insulin Resistance |
| US20100081707A1 (en) * | 2008-02-21 | 2010-04-01 | Ali Robin R | Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea |
| EP3741381B1 (en) * | 2008-02-26 | 2024-04-24 | Cornell University | A peptide for use for prevention and treatment of acute renal injury |
| ES2964555T3 (es) * | 2009-08-24 | 2024-04-08 | Stealth Biotherapeutics Inc | Péptido para uso en la prevención o tratamiento de la degeneración macular |
| CA2781309A1 (en) * | 2009-12-04 | 2011-06-09 | Euclid Systems Corporation | Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
| EP2590664B1 (en) * | 2010-07-09 | 2019-03-27 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury |
-
2013
- 2013-02-21 CN CN201380021305.4A patent/CN104244964A/zh active Pending
- 2013-02-21 CA CA2865317A patent/CA2865317A1/en not_active Abandoned
- 2013-02-21 WO PCT/US2013/027175 patent/WO2013126597A1/en not_active Ceased
- 2013-02-21 HK HK15105911.8A patent/HK1204988A1/xx unknown
- 2013-02-21 EP EP17165829.7A patent/EP3281634A1/en not_active Withdrawn
- 2013-02-21 EP EP18188192.1A patent/EP3479839A1/en not_active Withdrawn
- 2013-02-21 EP EP16159631.7A patent/EP3078384A1/en not_active Withdrawn
- 2013-02-21 CN CN201510796422.9A patent/CN105343869A/zh active Pending
- 2013-02-21 AU AU2013222423A patent/AU2013222423A1/en not_active Abandoned
- 2013-02-21 US US14/380,220 patent/US20150018288A1/en not_active Abandoned
- 2013-02-21 JP JP2014558832A patent/JP2015509500A/ja active Pending
- 2013-02-21 EP EP13751091.3A patent/EP2817018A4/en not_active Withdrawn
-
2016
- 2016-01-07 US US14/990,349 patent/US20160361377A1/en not_active Abandoned
-
2017
- 2017-06-06 JP JP2017111746A patent/JP2017214380A/ja active Pending
- 2017-10-31 AU AU2017254849A patent/AU2017254849A1/en not_active Abandoned
- 2017-11-29 US US15/825,298 patent/US20180296630A1/en not_active Abandoned
-
2018
- 2018-10-05 JP JP2018189741A patent/JP2019034947A/ja active Pending
-
2019
- 2019-05-28 AU AU2019203713A patent/AU2019203713A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509500A5 (https=) | ||
| Lewis et al. | Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction | |
| Waszczykowska et al. | Prevalence of ocular manifestations in systemic sclerosis patients | |
| Zarei-Ghanavati et al. | Cataract and diabetes: review of the literature | |
| CN105050600A (zh) | 眼底疾病治疗剂 | |
| CN111109198B (zh) | 一种葡萄膜炎动物模型构建方法 | |
| JP2024506384A5 (https=) | ||
| RU2014151992A (ru) | Лечение воспалительных заболеваний глаз с применением лахинимода | |
| Zheng et al. | Angle-closure glaucoma following periorbital botulinum toxin injection. | |
| KOLLARITS et al. | Norepinephrine therapy of ischemic optic neuropathy | |
| Yang et al. | Effect of anterior chamber paracentesis on initial treatment of acute angle closure | |
| JP2014510115A (ja) | 初期の緑内障における正常な視覚機能を回復するｐａｃａｐ（下垂体アデニル酸シクラーゼ活性化ポリペプチド）に基づく眼科用製剤 | |
| Ponomareva et al. | The effectiveness of local conservative therapy after panretinal laser coagulation against the background of diabetic neuropathy | |
| Economou et al. | Mantle cell lymphoma of the iris | |
| Wahab et al. | Combined phacoemulsification, vitrectomy and endolaser photocoagulation in patients with diabetic retinopathy and cataract | |
| Regenbogen et al. | Retinal detachments due to juxtapapillary microholes | |
| Berhuni et al. | Foveoschisis associated with gyrate atrophy in ornithine aminotransferase deficiency: a case report | |
| RU2558991C1 (ru) | Способ моделирования пролиферативной витреоретинопатии у крыс | |
| Kerimoglu et al. | Unilateral chemosis, acute onset myopia and choroidal detachment following the use of tamsulosin | |
| ALTAŞ | Angle Closure Glaucoma and Management in Geriatric Population | |
| Oga et al. | A Diagnosis of Occlusion | |
| Oga et al. | You're Getting on My Nerves | |
| RU2649534C1 (ru) | Способ анестезии при факоэмульсификации катаракты | |
| Lin | Observation on the clinical effect of cataract phacoemulsification combined with intraocular lens implantation | |
| Lamas et al. | Coats Disease in Young Patient with Congenital Cataracts History |